483 related articles for article (PubMed ID: 16539278)
1. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
4. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against beta2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome.
Ames PR; Delgado Alves J; Lopez LR; Gentile F; Margarita A; Pizzella L; Batuca J; Scenna G; Brancaccio V; Matsuura E
Clin Dev Immunol; 2006 Mar; 13(1):1-9. PubMed ID: 16603439
[TBL] [Abstract][Full Text] [Related]
6. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
8. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
9. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndrome.
Ames PR; Tommasino C; Fossati G; Matsuura E; Margarita A; Saulino A; Lopez L; Scenna G; Brancaccio V
Lupus; 2005; 14(10):809-13. PubMed ID: 16302675
[TBL] [Abstract][Full Text] [Related]
11. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
[TBL] [Abstract][Full Text] [Related]
12. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
[TBL] [Abstract][Full Text] [Related]
13. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune-mediated atherothrombosis.
Matsuura E; Lopez LR
Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
16. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
[TBL] [Abstract][Full Text] [Related]
18. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
19. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
Matsuura E; Lopez LR
Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
[TBL] [Abstract][Full Text] [Related]
20. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
Berger JS; Rockman CB; Guyer KE; Lopez LR
J Immunol Res; 2014; 2014():234316. PubMed ID: 25405208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]